These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 31063091)

  • 21. The epidemiology of Shiga toxin-producing Escherichia coli infections in the South East of England: November 2013-March 2017 and significance for clinical and public health.
    Carroll KJ; Harvey-Vince L; Jenkins C; Mohan K; Balasegaram S
    J Med Microbiol; 2019 Jun; 68(6):930-939. PubMed ID: 30994441
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization of Shiga Toxin-Producing Escherichia coli Isolated from Humans between 2011 and 2014.
    Gulesen R; Levent B; Demir T; Akgeyik M; Kuran S
    Jpn J Infect Dis; 2016 Sep; 69(5):390-4. PubMed ID: 26902213
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Outbreak of shiga toxin-producing Escherichia coli serotype O26: H11 infection at a child care center in Colorado.
    Brown JA; Hite DS; Gillim-Ross LA; Maguire HF; Bennett JK; Patterson JJ; Comstock NA; Watkins AK; Ghosh TS; Vogt RL
    Pediatr Infect Dis J; 2012 Apr; 31(4):379-83. PubMed ID: 22189536
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization of Shiga-toxigenic Escherichia coli isolated from cases of diarrhoea & haemolytic uremic syndrome in north India.
    Kumar A; Taneja N; Bharti B; Sharma M
    Indian J Med Res; 2014 Dec; 140(6):778-84. PubMed ID: 25758577
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Investigation of travel-related cases in a multinational outbreak: example of the Shiga-toxin producing E. coli outbreak in Germany, May-June 2011.
    Devaux I; Varela-Santos C; Payne-Hallström L; Takkinen J; Bogaardt C; Coulombier D
    Epidemiol Infect; 2015 Dec; 143(16):3468-74. PubMed ID: 25906969
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Epidemiology and microbiology of Shiga toxin-producing Escherichia coli other than serogroup O157 in England, 2009-2013.
    Byrne L; Vanstone GL; Perry NT; Launders N; Adak GK; Godbole G; Grant KA; Smith R; Jenkins C
    J Med Microbiol; 2014 Sep; 63(Pt 9):1181-1188. PubMed ID: 24928216
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Whole-genome sequencing for national surveillance of Shiga toxin-producing Escherichia coli O157.
    Dallman TJ; Byrne L; Ashton PM; Cowley LA; Perry NT; Adak G; Petrovska L; Ellis RJ; Elson R; Underwood A; Green J; Hanage WP; Jenkins C; Grant K; Wain J
    Clin Infect Dis; 2015 Aug; 61(3):305-12. PubMed ID: 25888672
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increased recognition of non-O157 Shiga toxin-producing Escherichia coli infections in the United States during 2000-2010: epidemiologic features and comparison with E. coli O157 infections.
    Gould LH; Mody RK; Ong KL; Clogher P; Cronquist AB; Garman KN; Lathrop S; Medus C; Spina NL; Webb TH; White PL; Wymore K; Gierke RE; Mahon BE; Griffin PM;
    Foodborne Pathog Dis; 2013 May; 10(5):453-60. PubMed ID: 23560425
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Foodborne general outbreaks of Shiga toxin-producing Escherichia coli O157 in England and Wales 1992-2002: where are the risks?
    Gillespie IA; O'Brien SJ; Adak GK; Cheasty T; Willshaw G
    Epidemiol Infect; 2005 Oct; 133(5):803-8. PubMed ID: 16181498
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Update on the ongoing outbreak of haemolytic uraemic syndrome due to Shiga toxin-producing Escherichia coli (STEC) serotype O104, Germany, May 2011.
    Askar M; Faber MS; Frank C; Bernard H; Gilsdorf A; Fruth A; Prager R; Hohle M; Suess T; Wadl M; Krause G; Stark K; Werber D
    Euro Surveill; 2011 Jun; 16(22):. PubMed ID: 21663710
    [No Abstract]   [Full Text] [Related]  

  • 31. Characteristics of the Shiga-toxin-producing enteroaggregative Escherichia coli O104:H4 German outbreak strain and of STEC strains isolated in Spain.
    Mora A; Herrrera A; López C; Dahbi G; Mamani R; Pita JM; Alonso MP; Llovo J; Bernárdez MI; Blanco JE; Blanco M; Blanco J
    Int Microbiol; 2011 Sep; 14(3):121-41. PubMed ID: 22101411
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The mosaic genome structure and phylogeny of Shiga toxin-producing Escherichia coli O104:H4 is driven by short-term adaptation.
    Zhou K; Ferdous M; de Boer RF; Kooistra-Smid AM; Grundmann H; Friedrich AW; Rossen JW
    Clin Microbiol Infect; 2015 May; 21(5):468.e7-18. PubMed ID: 25656624
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Results of surveillance for infections with Shiga toxin-producing Escherichia coli (STEC) of serotype O104:H4 after the large outbreak in Germany, July to December 2011.
    Frank C; Milde-Busch A; Werber D
    Euro Surveill; 2014 Apr; 19(14):. PubMed ID: 24739983
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Infections in pediatric postdiarrheal hemolytic uremic syndrome: factors associated with identifying shiga toxin-producing Escherichia coli.
    Mody RK; Luna-Gierke RE; Jones TF; Comstock N; Hurd S; Scheftel J; Lathrop S; Smith G; Palmer A; Strockbine N; Talkington D; Mahon BE; Hoekstra RM; Griffin PM
    Arch Pediatr Adolesc Med; 2012 Oct; 166(10):902-9. PubMed ID: 22869280
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dextran Sulfate Sodium Colitis Facilitates Colonization with Shiga Toxin-Producing Escherichia coli: a Novel Murine Model for the Study of Shiga Toxicosis.
    Hall G; Kurosawa S; Stearns-Kurosawa DJ
    Infect Immun; 2018 Nov; 86(11):. PubMed ID: 30150257
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Enhanced laboratory-based surveillance of Shiga-toxin-producing Escherichia coli O157 in The Netherlands.
    Van Duynhoven YT; De Jager CM; Heuvelink AE; Van Der Zwaluw WK; Maas HM; Van Pelt W; Wannet WJ
    Eur J Clin Microbiol Infect Dis; 2002 Jul; 21(7):513-22. PubMed ID: 12172742
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Public Health Investigation of Two Outbreaks of Shiga Toxin-Producing Escherichia coli O157 Associated with Consumption of Watercress.
    Jenkins C; Dallman TJ; Launders N; Willis C; Byrne L; Jorgensen F; Eppinger M; Adak GK; Aird H; Elviss N; Grant KA; Morgan D; McLauchlin J
    Appl Environ Microbiol; 2015 Jun; 81(12):3946-52. PubMed ID: 25841005
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Surveillance of hemolytic uremic syndrome in children less than 15 years of age, a system to monitor O157 and non-O157 Shiga toxin-producing Escherichia coli infections in France, 1996-2006.
    Espié E; Grimont F; Mariani-Kurkdjian P; Bouvet P; Haeghebaert S; Filliol I; Loirat C; Decludt B; Minh NN; Vaillant V; de Valk H
    Pediatr Infect Dis J; 2008 Jul; 27(7):595-601. PubMed ID: 18520972
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vero cytotoxin-producing Escherichia coli, particularly serogroup O157, associated with human infections in England and Wales: 1992-4.
    Thomas A; Cheasty T; Frost JA; Chart H; Smith HR; Rowe B
    Epidemiol Infect; 1996 Aug; 117(1):1-10. PubMed ID: 8760944
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An epidemiologic surveillance of Shiga-like toxin-producing Escherichia coli infection in Argentinean children: risk factors and serum Shiga-like toxin 2 values.
    López EL; Contrini MM; Glatstein E; Ayala SG; Santoro R; Ezcurra G; Teplitz E; Matsumoto Y; Sato H; Sakai K; Katsuura Y; Hoshide S; Morita T; Harning R; Brookman S
    Pediatr Infect Dis J; 2012 Jan; 31(1):20-4. PubMed ID: 21829137
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.